GRITSTONE BIO INC
(NASDAQ: GRTS)

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

2.790

+0.200 (+7.72%)
Range 2.640 - 2.895   (9.66%)
Open -
Previous Close 2.590
Bid Price 1.840
Bid Volume 18
Ask Price 1.920
Ask Volume 31
Volume 2,012,250
Value -
Remark
Delayed prices. Updated at 28 Mar 2024 03:59.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis